Platelets reduce tumor cell recognition and cytotoxicity by NK cells by reducing the expression of CD112 and CD155 on tumor cells and their related receptors CD226 and CD96 on the NK cells (40) (Figure 4). The gene discussed is CD226; the disease is neoplasm.